InvestorsHub Logo
Followers 17
Posts 1412
Boards Moderated 0
Alias Born 11/01/2018

Re: Reyeton post# 230184

Monday, 01/13/2020 10:09:37 PM

Monday, January 13, 2020 10:09:37 PM

Post# of 455325
Reyton - This is huge. This patent was for 5 neurodevelopment disorders. Worth a lot of money.


The United States Patent and Trademark Office (USPTO) granted a patent to Anavex Life Sciences covering Anavex 2-73 (blarcamesine) as a potential therapy for neurodevelopmental disorders, including Rett syndrome.

The patent (No. 10,507,196) is valid until at least 2037 and also covers methods of treatment based on Anavex 2-73 for other disorders including multiple sclerosis, Angleman Syndrom, Cerebral Palsy and Autism spectrum disorders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News